Breast Care· 2016Q2· Review
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- 30,918citations
- Q2SCImago
- 2016year
Short summary
Immune checkpoint inhibition, specifically blocking PD-1 and PD-L1, shows significant promise for treating breast cancer, particularly triple-negative subtypes, potentially leading to long-term disease control.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Oncology
OncologyMedicine